Supraventricular tachycardia caused by nebulised ipratropium bromide.
A 71 year old patient developed a supraventricular tachycardia after the administration of nebulised ipratropium bromide.
O'Driscoll
B R
BR
Department of Thoracic Medicine, Wythenshawe Hospital, Manchester.
D000281:Administration, Intranasal; D000368:Aged; D001286:Atropine Derivatives / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage / Q000009:adverse effects*; D009330:Nebulizers and Vaporizers; D013617:Tachycardia, Supraventricular / Q000139:chemically induced*
D001286:Atropine Derivatives; D009241:Ipratropium